Medical Properties Trust Earnings Call Transcripts
Fiscal Year 2025
-
Portfolio EBITDARM coverage improved to 2.6x year-over-year, with strong gains in acute and post-acute segments. Normalized FFO reached $0.18 per share for Q4, and the company expects to surpass $1 billion in annualized cash rent by end of 2026.
-
Tenants delivered strong operational and financial results, with significant EBITDARM growth across segments and robust international performance. Asset sales, a new $150 million share repurchase program, and strategic refinancing support liquidity and future rent growth.
-
Q2 2025 featured strong rent growth from new tenants, robust international and U.S. operator performance, and successful refinancing activities. Normalized FFO was $0.14 per share, with asset sales and capital strategies supporting future growth.
-
Q1 2025 featured strong operational and financial performance, highlighted by a $2.5B bond issuance, portfolio-wide volume and revenue growth, and successful transitions to new operators. Despite impairments and ongoing Steward bankruptcy challenges, annualized cash rent is projected to exceed $1B as new tenants ramp up.
Fiscal Year 2024
-
Liquidity was significantly strengthened with $3B in transactions and $2.5B in secured bonds, covering all maturities through 2026. Q4 saw a $413M net loss due to Prospect-related impairments, but normalized FFO was $0.18 per share. Portfolio fundamentals and cash flows are improving, with new operators ramping up.
-
Q3 2024 saw a global settlement with Steward, re-tenanting of 17 properties, and over $2.9B in asset sales. Despite a GAAP net loss of $1.34 per share due to one-time charges, normalized FFO was $0.16. Cash rent is expected to exceed $1B annually by 2026.
-
Q2 2024 saw strong liquidity generation, full repayment of 2024 debt, and improving hospital portfolio performance. Steward Health Care's bankruptcy continues to pose uncertainty, but asset sales and re-tenanting are progressing, with a stable outlook for 2026 and beyond.